CAI · Healthcare
CARIS LIFE SCIENCES INC
Smart-money confidence
· 1 of 3 sources firing
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
40
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
◆ Next steps
Interested in CARIS LIFE SCIENCES INC? Here's what to do with it.
◇
Compare with other stocks
Sort 7,111 stocks by confidence, holders, or Congress signal
◈
Backtest the strategy
See how the model has done historically before you commit real money
✉
Get the weekly digest
One email on Sunday · what changed in the model this week
Not financial advice. Bogen Capital surfaces public SEC filings — you decide what to do with them.
Market cap
$4.5B
Industry
Biotechnology
Sector
Healthcare
Exchange
NasdaqGS
About CARIS LIFE SCIENCES INC
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome…
Who's behind the signal
Every informed buyer we can see on CAI, across all three feeds.
Hedge funds · 7
Citadel Advisors
New position
Point72 (Steve Cohen)
Increased +656%
ARK Invest (Cathie Wood)
Increased +67%
Gotham Asset Mgmt (Greenblatt)
Increased +102%
Coatue Management
Decreased −3%
Millennium Management (Englander)
Decreased −7%
+1 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar.
CARIS LIFE SCIENCES INC isn't in the top-10 model right now, but 7 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
7
Investors
1
New positions
3
Increasing
3
Decreasing
0
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.0×
% of portfolio
0.1%
Position change
NEW
0.1% of Citadel Advisors's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
+656%
0.1% of Point72's portfolio
Trust weight: 1.3×
% of portfolio
0.1%
Position change
+67%
0.1% of ARK Invest's portfolio
Trust weight: 1.1×
% of portfolio
0.0%
Position change
+102%
0.0% of Gotham Asset Mgmt's portfolio
Trust weight: 1.4×
% of portfolio
0.7%
Position change
−3%
0.7% of Coatue Management's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
−7%
0.1% of Millennium Management's portfolio
Trust weight: 1.2×
% of portfolio
0.0%
Position change
−31%
0.0% of Tudor Investment's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to CARIS LIFE SCIENCES INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell CARIS LIFE SCIENCES INC or any security.
Get the Weekly Update
Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime